GSK: A Case Study
China Law and Practice, July/August 2014
The Chinese government has substantially beefed up its anti-corruption enforcement in recent years, resulting in arrests and trials of high-level state officials and prominent executives of state-owned (SOEs) as well as multinational companies (MNCs).
Copy link to share post